285 related articles for article (PubMed ID: 19484742)
61. Control of tissue growth and cell transformation by the Salvador/Warts/Hippo pathway.
Zhang X; Grusche FA; Harvey KF
PLoS One; 2012; 7(2):e31994. PubMed ID: 22359650
[TBL] [Abstract][Full Text] [Related]
62. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.
Yin F; Yu J; Zheng Y; Chen Q; Zhang N; Pan D
Cell; 2013 Sep; 154(6):1342-55. PubMed ID: 24012335
[TBL] [Abstract][Full Text] [Related]
63. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade.
Lodge EJ; Santambrogio A; Russell JP; Xekouki P; Jacques TS; Johnson RL; Thavaraj S; Bornstein SR; Andoniadou CL
Elife; 2019 Mar; 8():. PubMed ID: 30912742
[TBL] [Abstract][Full Text] [Related]
64. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
Werneburg N; Gores GJ; Smoot RL
Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
[TBL] [Abstract][Full Text] [Related]
65. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway.
Boggiano JC; Vanderzalm PJ; Fehon RG
Dev Cell; 2011 Nov; 21(5):888-95. PubMed ID: 22075147
[TBL] [Abstract][Full Text] [Related]
66. The regulatory mechanisms and functional roles of the Hippo signaling pathway in breast cancer.
Yao CB; Zhou X; Chen CS; Lei QY
Yi Chuan; 2017 Jul; 39(7):617-629. PubMed ID: 28757476
[TBL] [Abstract][Full Text] [Related]
67. The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster.
Grusche FA; Degoutin JL; Richardson HE; Harvey KF
Dev Biol; 2011 Feb; 350(2):255-66. PubMed ID: 21111727
[TBL] [Abstract][Full Text] [Related]
68. Estrogen regulates Hippo signaling via GPER in breast cancer.
Zhou X; Wang S; Wang Z; Feng X; Liu P; Lv XB; Li F; Yu FX; Sun Y; Yuan H; Zhu H; Xiong Y; Lei QY; Guan KL
J Clin Invest; 2015 May; 125(5):2123-35. PubMed ID: 25893606
[TBL] [Abstract][Full Text] [Related]
69. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.
Azad T; Janse van Rensburg HJ; Lightbody ED; Neveu B; Champagne A; Ghaffari A; Kay VR; Hao Y; Shen H; Yeung B; Croy BA; Guan KL; Pouliot F; Zhang J; Nicol CJB; Yang X
Nat Commun; 2018 Mar; 9(1):1061. PubMed ID: 29535383
[TBL] [Abstract][Full Text] [Related]
70. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
71. YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer.
Hergovich A
Breast Cancer Res; 2012 Dec; 14(6):326. PubMed ID: 23216692
[TBL] [Abstract][Full Text] [Related]
72. The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance.
Emoto K; Parrish JZ; Jan LY; Jan YN
Nature; 2006 Sep; 443(7108):210-3. PubMed ID: 16906135
[TBL] [Abstract][Full Text] [Related]
73. Upstream regulation of the hippo size control pathway.
Grusche FA; Richardson HE; Harvey KF
Curr Biol; 2010 Jul; 20(13):R574-82. PubMed ID: 20619814
[TBL] [Abstract][Full Text] [Related]
74. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network.
Harvey K; Tapon N
Nat Rev Cancer; 2007 Mar; 7(3):182-91. PubMed ID: 17318211
[TBL] [Abstract][Full Text] [Related]
75. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
[TBL] [Abstract][Full Text] [Related]
76. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer.
Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP
Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148
[TBL] [Abstract][Full Text] [Related]
77. Delineation of a Fat tumor suppressor pathway.
Cho E; Feng Y; Rauskolb C; Maitra S; Fehon R; Irvine KD
Nat Genet; 2006 Oct; 38(10):1142-50. PubMed ID: 16980976
[TBL] [Abstract][Full Text] [Related]
78. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
[TBL] [Abstract][Full Text] [Related]
79. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms.
Grzeschik NA; Parsons LM; Allott ML; Harvey KF; Richardson HE
Curr Biol; 2010 Apr; 20(7):573-81. PubMed ID: 20362447
[TBL] [Abstract][Full Text] [Related]
80. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.
Zinatizadeh MR; Miri SR; Zarandi PK; Chalbatani GM; Rapôso C; Mirzaei HR; Akbari ME; Mahmoodzadeh H
Genes Dis; 2021 Jan; 8(1):48-60. PubMed ID: 33569513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
